12-Month Lobbying Summary - Organization

Boehringer Ingelheim Canada Ltd / Mark Lewis, President and CEO

Registration Summary

Currently active - Last Updated: 2024-01-01

Who is lobbying?

Boehringer Ingelheim Canada Ltd (Address & business activities)

Mark Lewis, President and CEO

Senior Officer in previous versions
- Annie Beauchemin, Head, Market Access
- Andrea Sambati, President & CEO

Government Funding

Did Boehringer Ingelheim Canada Ltd request or receive government funding within the last 12 months? No

Coalition Members Information

Boehringer Ingelheim Canada Ltd is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Boehringer Ingelheim Canada Ltd has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Boehringer Ingelheim International GmbH (Address information)

Other Affiliates

The activities of Boehringer Ingelheim Canada Ltd are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Boehringer Ingelheim Canada Ltd:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discuss healthcare improvement partnerships	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly	Indigenous Relations and Reconciliation
Facilitate the development of framework to enable public-private-partnerships to support health system efficiency and patient outcomes. An example is our partnership with the Canadian Foundation for Healthcare Improvement (CFHI).	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly	Economic Development and Trade, Health
Providing education regarding healthcare innovation, pharmaceutical investment, health policy and patient-centered initiatives in BC	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Science and Technology
To actively promote the contributions and positive impact of pharmaceutical innovation and the innovative pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system. Ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals. Work with the Ministry of Health regarding public reimbursement of our innovative pharmaceutical products	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Indigenous Relations and Reconciliation
Member(s) of the BC Legislative Assembly

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Mehmood Alibhai
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2017-04-11 and before 2020-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2020-09-21: Yes	Political: No Sponsorship: No Recall: No

Marc O'Loughlin
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2017-04-11 and before 2020-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2020-09-21: Yes	Political: No Sponsorship: No Recall: No

Andrew Ransom
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2017-04-11 and before 2020-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2020-09-21: Yes	Political: No Sponsorship: No Recall: No

Lobbyists in previous versions

In-house Lobbyists
Lobbyist	BC Former Public Office Holder Positions	Contributions
Andrea Sambati	Former Public Office Holder in BC: No	Contributions: No

Registration number: 9781-331
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

No monthly Lobbying Activity Reports have been submitted for the last 12 months.

View all Lobbying Activity Reports

Return to 12-Month Lobbying Activity Search Results

Boehringer Ingelheim Canada Ltd - Address & business activities

Address:

5180 S Service Rd
Burlington, ON L7L 5H4
Canada

Telephone number: 905-639-0333

Contact information in previous versions
- 9655 Woodward Pl
  Richmond, BC V7E 1H5
  Canada
  
  Telephone number: 604-644-3171
- 9655 Woodward Pl
  
  Richmond, BC V7E 1H5
  Canada
  
  Telephone number: 604-644-3171
- 9655 woodward's pl
  9655 woodward's pl
  richmond, BC V7E 1H5
  Canada
  
  Telephone number: 604-275-0859
- 9655 Woodward's Pl
  
  Richmond, BC V7E 1H5
  Canada
  
  Telephone number: 604-644-3171
- 5180 South Service Road
  
  Burlington, ON L7L 5H4
  Canada
  
  Telephone number: 905-639-0333
- 5180 South Service Road
  
  Burlington , ON L7L 5H4
  Canada
  
  Telephone number: 780-464-9926
- 5180 South Service Road
  
  Burlington , ON L7L 5H4
  Canada
  
  Telephone number: 905-631-4757

Description of Activities:
Researcher, developer, manufacturer of pharmaceuticals.

Descriptions of the organization's activity in previous versions:
- Researcher, developer and manufacturer of pharmaceuticals.
- Pharmaceutical research, development and manufacturing.
- Research based pharmaceutical Company
- Research Based Pharmaceutical Company

Date Modified:: 2024-01-29

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

Boehringer Ingelheim Canada Ltd / Mark Lewis, President and CEO

Who is lobbying?

Boehringer Ingelheim Canada Ltd (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

Boehringer Ingelheim Canada Ltd / Mark Lewis, President and CEO

Boehringer Ingelheim Canada Ltd (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Ministries/Provincial Entities

Boehringer Ingelheim Canada Ltd - Address & business activities

Boehringer Ingelheim Canada Ltd / Mark Lewis, President and CEO

Boehringer Ingelheim International GmbH